Udg Healthcare PLC (LON:UDG) Given Average Rating of “Hold” by Brokerages

Udg Healthcare PLC (LON:UDG) has received a consensus recommendation of “Hold” from the seven ratings firms that are covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 747.50 ($9.77).

Several research firms have weighed in on UDG. Berenberg Bank lifted their target price on Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the stock a “hold” rating in a report on Tuesday. Liberum Capital reissued a “buy” rating on shares of Udg Healthcare in a research note on Wednesday, August 7th. Peel Hunt reissued a “buy” rating on shares of Udg Healthcare in a research note on Wednesday, August 7th. Royal Bank of Canada downgraded Udg Healthcare to a “sector performer” rating and dropped their price target for the company from GBX 830 ($10.85) to GBX 800 ($10.45) in a research note on Monday, August 12th. Finally, Numis Securities raised Udg Healthcare to a “hold” rating in a research note on Thursday, May 16th.

UDG stock traded up GBX 5.50 ($0.07) during midday trading on Wednesday, hitting GBX 817.50 ($10.68). 1,872,040 shares of the company’s stock were exchanged, compared to its average volume of 981,360. The stock’s fifty day moving average price is GBX 783.87 and its 200-day moving average price is GBX 681.64. The company has a debt-to-equity ratio of 26.96, a quick ratio of 1.85 and a current ratio of 1.94. The company has a market cap of $2.04 billion and a PE ratio of 79.37. Udg Healthcare has a one year low of GBX 545 ($7.12) and a one year high of GBX 819 ($10.70).

Udg Healthcare Company Profile

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

Further Reading: Cost of Goods Sold (COGS)

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.